Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data
Daichi Shigemizu, Shintaro Akiyama, Sayuri Higaki, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Omics in Systems Biology: Current Progress and Future Outlook
Timothy D. Veenstra
PROTEOMICS (2020) Vol. 21, Iss. 3-4
Closed Access | Times Cited: 73
Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application
Minghui Wang, Won‐Min Song, Ming Chen, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 66
Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Yanru Chen, Xiaoling Qian, Yuanyuan Zhang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 51
AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease
Chengsheng Mao, Jie Xu, Luke V. Rasmussen, et al.
Journal of Biomedical Informatics (2023) Vol. 144, pp. 104442-104442
Open Access | Times Cited: 24
Data analysis with Shapley values for automatic subject selection in Alzheimer’s disease data sets using interpretable machine learning
Louise Bloch, Christoph M. Friedrich
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Curve Walking Reveals More Gait Impairments in Older Adults with Mild Cognitive Impairment than Straight Walking: A Kinect Camera-Based Study
Mahmoud Seifallahi, James E. Galvin, Behnaz Ghoraani
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 423-435
Open Access | Times Cited: 6
Elucidating the Link Between Anxiety/Depression and Alzheimer’s Dementia in the Australian Imaging Biomarkers and Lifestyle (AIBL) Study
Liwei Ma, Edwin C.K. Tan, Ashley I. Bush, et al.
Journal of Epidemiology and Global Health (2024) Vol. 14, Iss. 3, pp. 1130-1141
Open Access | Times Cited: 6
The ketone body β‐hydroxybutyrate shifts microglial metabolism and suppresses amyloid‐β oligomer‐induced inflammation in human microglia
Lee‐Way Jin, Jacopo Di Lucente, Ulises Ruiz Mendiola, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 15
A review and analysis of key biomarkers in Alzheimer’s disease
Zhihao Zhang, Xiangtao Liu, Suixia Zhang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
The fusion of multi-omics profile and multimodal EEG data contributes to the personalized diagnostic strategy for neurocognitive disorders
Yan Han, Xinglin Zeng, Lin Hua, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Usage patterns of cognitive assessments during Medicare's Annual Wellness Visit: A national survey
Ying Liu, T Ozawa, Soeren Mattke
Alzheimer s & Dementia (2025)
Open Access
Alzheimer’s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles
Hash Brown Taha
(2025) Vol. 1, Iss. 1
Open Access
Unraveling the transcriptome of pyramidal neurons from human hippocampus under aging, amnestic mild-cognitive impairment, and sex-interactions
Daniel V. Guebel
Exploration of Medicine (2025)
Open Access
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
Natalia Ogonowski, Stefanny Salcidua, Tomás León, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 21
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Lanlan Li, Xianfeng Yu, Can Sheng, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer’s disease
Qi Zhang, Bi‐Shuang Chen, Ping Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 18
A Machine Learning Classifier for Predicting Stable MCI Patients Using Gene Biomarkers
Run-Hsin Lin, Chia‐Chi Wang, Chun-Wei Tung
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4839-4839
Open Access | Times Cited: 16
The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer’s disease
Christopher Clark, Miriam Rabl, Loı̈c Dayon, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function
Seong Beom Cho
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2211-2211
Open Access | Times Cited: 3
Extracellular Vesicles for Alzheimer’s Disease and Dementia Diagnosis
Hash Brown Taha
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Detection of mild cognitive impairment using various types of gait tests and machine learning
Mahmoud Seifallahi, James E. Galvin, Behnaz Ghoraani
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Antonio José Cañada Martínez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1812-1812
Open Access | Times Cited: 21
Non-coding RNAs in Alzheimer’s disease: perspectives from omics studies
Erming Wang, Mariana Lemos Duarte, Lauren E Rothman, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. R1, pp. R54-R61
Open Access | Times Cited: 14
Preliminary exploration of the co-regulation of Alzheimer’s disease pathogenic genes by microRNAs and transcription factors
Qi Zhang, Ping Yang, Xinping Pang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 14
Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: A Texas Alzheimer’s Research and Care Consortium (TARCC) Cohort-Based Analysis
Haitham Salem, Robert Suchting, Mitzi M. Gonzales, et al.
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 1, pp. 129-139
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top